pre-update Archives

Announcement

Certara’s Synchrogenix Writer now enhanced with AI Layar

Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…

CertaraMay 11, 2023

Press Coverage

The Impact of the Inflation Reduction Act on Biosimilar Uptake

In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…

CertaraMay 8, 2023

Blog

What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?

A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…

CertaraMay 4, 2023

Press Coverage

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

2023 guidance from FDA on dosages in oncology provides further context on expectations with Project…

CertaraMay 3, 2023

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

On-Demand Webinar

Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis

Published research and literature-based content holds valuable insight that can inform clinical trial execution and…

CertaraApril 19, 2023

On-Demand Webinar

Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…

CertaraApril 17, 2023

White Paper

Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program

This white paper focuses on best practices for developing a CMC strategy for orally administered…

CertaraApril 13, 2023

Video

Milestone Achieved: Simcyp 100

CertaraApril 11, 2023

Brochure

Drug Discovery & Development with Deep Learning Advanced Analytics

Solutions to Meet All Needs: From Small Biotech to Large Global Pharma

CertaraApril 6, 2023

pre-update